Healthy Members & a

Healthier Bottom Line

Tria Health provides one all-encompassing solution to prevent and manage chronic conditions. We improve health and reduce costs, guaranteed.

Person standing on arrow and holding flag

Tria Health assesses HEDIS® and T-MED   metrics in order to identify gaps in care, and then works with members to close open care gaps over time.

We

Heart

HEDIS

®

During our one-on-one member consultations, Tria Health’s pharmacists capture Healthcare Effectiveness Data and Information Set (HEDIS®) metrics, which are a standardized set of healthcare measurements, varied by different chronic disease states, used to determine if a member is effectively managing his or her disease. 

T-MED

Pill

Our pharmacists also capture other Tria-proprietary Medication Effectiveness Data (T-MED   ), both pharmacological and nonpharmacological (e.g., lifestyle metrics, barriers to adherence, and condition management education), which are also critical and provide a more comprehensive measurement of effective condition management.

Validation Institute Seal

Our Results are

Validated.

Tria Health’s Pharmacy Advocate Program was independently validated by the Validation Institute to determine health care cost reduction for members engaged in the Tria Health program. The Validation Institute validated a 41% reduction in in-patient hospital cost and 59% reduction in emergency room costs in a matched cohort study.

To view the full report, click here.

Emergency Room Visits Lower for Tria Health

Emergency department per member costs -41% 89% % Change: 2017-2019 37% 14% % Change: 2018-2019 -48% 38% % Change: 2017-2018

Hospital Costs Lower for Tria Health

Inpatient per member costs -59% 94% % Change: 2017-2019 -32% -24% % Change: 2018-2019 -46% 185% % Change: 2017-2018

Talking to a Pharmacist Results in Closed Care Gaps

Pharmacists Close

Care Gaps

Clinical care gaps are based on HEDIS® and T-MED measures, clinical practice guideline recommendations, and established evidence-based assessments.

 

Results of this 5-year retrospective study illustrate that inclusion of Tria Health pharmacist interventions assisted in closing over 50% of the open clinical care gaps across the chronic conditions investigated.

To view the full report, click here.

#TriaTriumph
Male Portrait
Trevor W.

Trevor called into a consultation, reporting that he had recently been diagnosed with atrial fibrillation. He started on Eliquis, a blood thinner that prevents strokes in the setting of atrial fibrillation. However, this medication comes with risk as any blood thinner can lead to bleeding complications.

 

Prior to taking Eliquis, Trevor was on Duexis (ibuprofen/famotidine) for arthritis pain. This medication is very expensive, almost $30,000 per year. Furthermore, long-term use of Duexis can lead to an increased risk of bleeding complications, specifically bleeding stomach ulcers. With the addition of Eliquis, Duexis became a potentially dangerous choice for Trevor. 

 

Tria Health's pharmacist reviewed the risks with Trevor and he was able to switch to a safer over-the-counter alternative for arthritis pain.